Marvel Biosciences Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRVL.V | QNTM | CNSP | PCSA | NIKI | SILO | |
|---|---|---|---|---|---|---|
| Market cap | 8.84M | 15.88M | 7.05M | 4.84M | 6.01M | 2.50M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -0.3 | -12.4 | -0.5 | — | -1.7 |
| Price/book | -2.8 | 2.4 | 0.4 | -15.2 | 0.1 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −36.84% | −82.16% | −41.88% | −74.24% | −86.38% | −85.21% |
| Today | 0.00% | +1.65% | −3.31% | 0.00% | −5.11% | +5.17% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MRVL.V news ›Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
CALGARY, Alberta, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF) , and its wholly-owned subsidiary, Marv... Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and…
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Preliminary Results Demonstrate Broad Activity of MB-204 The Shank3 findings add to a growing body of preclinical evidence generated for MB-204 across genetically distinct models of neurodevelopmental disorders. Marvel has previously…
Marvel Biosciences Secures Financial Support For the Phase 1 Trial of MB-204
Published on 04/07/2026 at 11:31 am EDT Canada futures fall as higher yields weigh on sentiment October 08, 2026 at 05:40 am EDT Bond Markets Are Giving Stocks a Headache TSX posts steepest decline in four months as bond yields climb TSX…
Marvel Biosciences Corp.: Relative Strength Chart - Stock Toronto S.E.
Compare Marvel Biosciences Corp. with the company of your choice via a Relative Strength chart. Real-time MRVL price, Toronto S.E. stock exchange Relative Strength Chart Marvel Biosciences Corp. Biotechnology & Medical Research All…
Marvel Biosciences Closes Private Placement
Marvel Biosciences closed its non-brokered private placement raising CA$1.6 million, it said in a statement late Tuesday. The offering consisted of the issuance of 10.7-million units at CA$0.15... Biotechnology & Medical Research Marvel…
Marvel Biosciences Corp. : Insider Transactions
Follow insider transactions on Marvel Biosciences Corp. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Marvel Biosciences Corp. Biotechnology & Medical Research Latest…
All Transcripts on Marvel Biosciences Corp. (MRVL)
Find all the latest transcripts on Marvel Biosciences Corp. Transcripts Marvel Biosciences Corp. Biotechnology & Medical Research All financial news and data tailored to specific country editions
Marvel Biosciences Corp.: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Marvel Biosciences Corp. on MarketScreener. Press Releases Marvel Biosciences Corp. Biotechnology & Medical Research All financial news and data tailored to specific…
Marvel Biosciences Corp.: Latest Headlines - Toronto S.E. Stock Exchange
Find the latest highlights on Marvel Biosciences Corp. at the Toronto S.E. stock exchange. Highlights Marvel Biosciences Corp. Biotechnology & Medical Research All financial news and data tailored to specific country editions
Marvel Biosciences Corp.: News in other languages | MRVL | CA57384M1077
Marvel Biosciences Corp.: News, information and stories for Marvel Biosciences Corp. | Toronto S.E.: MRVL | Toronto S.E. Other languages Marvel Biosciences Corp. Biotechnology & Medical Research All financial news and data tailored to…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com16
-
investingnews.com1
-
markets.businessinsider.com1
-
newsfilecorp.com1
-
stocktitan.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 20 articles, not a forecast.